Canopy Growth (CGC) Change in Inventory (2019 - 2026)
Canopy Growth (CGC) posted Change in Inventory of $6.3 million for Q4 2025, up 406.37% sequentially from -$2.0 million in Q2 2025, and up 820.81% YoY from $681488.4 in Q4 2024.
Canopy Growth (CGC) Change in Inventory (2019 - 2026) Analysis & Trends
Canopy Growth has reported Change in Inventory for 7 years, with the latest figure at $6.3 million in Q4 2025.
- Quarterly Change in Inventory rose 820.81% year-over-year to $6.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.5 million (up 215.98% YoY) and the FY2026 annual result came in at -$2.7 million, down 121.91% from the prior year.
- Change in Inventory improved to $6.3 million in Q4 2025 per CGC's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $14.8 million in Q2 2021 and troughed at -$155.9 million in Q1 2022.
- A 5-year average of -$12.2 million and a median of -$491925.9 in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory sank 657.8% in 2022, then soared 820.81% in 2025.
- Over 5 years, Change in Inventory stood at -$8.0 million in 2021, then surged by 122.79% to $1.8 million in 2022, then soared by 52.75% to $2.8 million in 2023, then sank by 75.63% to $681488.4 in 2024, then jumped by 820.81% to $6.3 million in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered $6.3 million, -$2.0 million, and $681488.4 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | -2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.50 Mn |
| Jun 30, 2026 | -2.50 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Dec 31, 2024 | 681,488.38 |
| Dec 31, 2024 | 681,488.38 |
| Sep 30, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | -6.74 Mn |
| Mar 31, 2024 | -6.74 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Jun 30, 2023 | -1.67 Mn |